GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Achillion Pharmaceuticals, Inc. (ACHN) [hlAlert]

Achillion Pharmaceuticals, Inc. (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, it focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the
treatment of resistant bacterial infections. As of December 31, 2008, Achillion focused its efforts on advancing two late-stage preclinical candidates: ACH-1095, an NS4A antagonist for the treatment of chronic hepatitis C, being developed in collaboration with Gilead Sciences, Inc. (Gilead), and ACH-1625, a protease inhibitor also for the treatment of chronic hepatitis C. It has a pipeline of other product candidates, for which it is seeking appropriate collaborative partners. These product candidates include elvucitabine for the treatment of human immunodeficiency virus (HIV) infection and ACH-702 for the treatment of serious bacterial infections.
.
( Total: 15 Current Stock Recommendations )
Achillion Pharmaceuticals, Inc.   (15)
Sell Hold 27% Buy 67%
Related companies
Astrazeneca Plc   (20)
Sell 30% Hold 40% Buy 30%
Glaxosmithkline Plc   (19)
Sell 16% Hold 63% Buy 21%
Abbott Laboratories   (29)
Sell Hold 24% Buy 69%
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Prestige Brand ...   (6)
Sell 17% Hold 50% Buy 33%
Filter by Gains:   
  
Rating:
Buy ACHN
down 4.45 %

Rating:
Hold ACHN
up 66.74 %

Rating:
Buy ACHN
down 18.81 %
Achillion Pharmaceuticals, Inc. (ACHN) rated Buy by Maxim Group
Friday,  Aug 15, 2014  12:00 AM ET

Rating:
Buy ACHN
up 9.95 %

Rating:
Buy ACHN
up 108.03 %

Rating:
Hold ACHN

Rating:
Hold ACHN

Rating:
Sell ACHN
down 62.91 %

Rating:
Hold ACHN

Rating:
Hold ACHN

Rating:
Buy ACHN
down 23.49 %

Rating:
Buy ACHN
up 66.74 %

Rating:
Buy ACHN
down 20.10 %

Rating:
Buy ACHN
down 62.91 %
Achillion Pharmaceuticals, Inc. (ACHN) rated Buy by BofA/Merrill
Wednesday,  Sep 19, 2012  8:25 AM ET

Rating:
Buy ACHN
up 18.26 %

Your Recent Stocks
SymbolLastChange
ACHN 7.05 down  -6.12 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy